New International Working Group Formed to Tackle Questions of Antibody Validation | GenomeWeb

NEW YORK (GenomeWeb) – In another sign of the life science community's increasing concern about antibody quality, a team led by Mathias Uhlén of the Royal Institute of Technology in Stockholm has formed a new working group to develop guidelines for validation and use of these reagents.

The International Working Group on Antibody Validation held its first meeting last month in Vancouver, Canada, coinciding with the Human Proteome Organization's annual meeting. According to Uhlén, it aims to have a set of guidelines it can present in a white paper at next year's HUPO meeting.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.